{
    "nctId": "NCT05817227",
    "briefTitle": "Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.",
    "officialTitle": "Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Use of immunohistochemistry investigation (IHC)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* TNBC breast cancer patients, before any drug treatment\n* healthy women aged 25-60\n\nExclusion Criteria:\n\n* donors suffering from diabetes, hypertension, active infectious states, HIV infection, Hepatitis B or C, chronic inflammatory diseases, current or previous neoplasms, heart disease or drug treatment.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}